Equagesic en es it fr

Equagesic Brand names, Equagesic Analogs

Equagesic Brand Names Mixture

  • No information avaliable

Equagesic Chemical_Formula


Equagesic RX_link

No information avaliable

Equagesic fda sheet

Equagesic msds (material safety sheet)

Equagesic Synthesis Reference

No information avaliable

Equagesic Molecular Weight

309.469 g/mol

Equagesic Melting Point

< 25 oC

Equagesic H2O Solubility

Soluble as HCl salt

Equagesic State


Equagesic LogP


Equagesic Dosage Forms

Tablets (oral, 1 mg)

Equagesic Indication

Used for the symptomatic treatment of parkinsonism.

Equagesic Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Equagesic Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Equagesic side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Equagesic Patient Information

Equagesic Organisms Affected

Humans and other mammals